Health Care

Commentary

Read about latest problems with Obamacare

Enhanced Obamacare Subsidies Irresistibly Inviting for Fraud

A new study from the Paragon Health Institute reveals that they’re also an invitation to fraud. As many as five million people receive free, taxpayer-funded marketplace coverage even though they’re not eligible for such largesse. It’s far from clear how many of these patients are deliberately misleading the government and ...
Commentary

Read about the latest push for government health care

Cross out Medicare X

Democrats argue that Medicare X “would help achieve universal health care by making coverage more affordable and accessible,” especially in rural communities. Democrats claim that they just want to offer another health insurance choice. But Medicare X would simply nudge us along toward the Democrats’ endgame: a complete government takeover ...
Commentary

Fix the 340B Program to Increase Access to Medicine

House lawmakers recently introduced legislation that would at last repair a program meant to provide low-income Americans with affordable medicine. In theory, the federal 340B Program, named after the section of the 1992 law establishing it, allows hospitals serving underprivileged groups to buy medications at steep discounts. The idea was ...
Commentary

Making Medical Debts ‘Disappear’ Misguided

The Biden administration proposed a rule this month that would remove medical debt from credit reports. It’s sure to be popular, if for no other reason than that it’s expected to boost credit scores for the more than 15 million people with such debt by an average of 20 points. ...
Commentary

Small-Molecule Price Controls Are Short-Sighted

There’s never been a better time to get lung cancer in the United States. That may sound morbid. But this deadliest of cancers appears to be losing a bit of its punch. The combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over ...
Commentary

Thanks to Biden, US Insurance Market Takes It in the Teeth

When in doubt, mandate. That has long been one of the unspoken principles guiding the left’s approach to health policy. A newly finalized rule from the Biden administration offers a fresh example of this pathology in action. Starting in 2027, the reform gives states the option of adding coverage for adult dental ...
Commentary

Learn about Sen. Sanders' latest scheme to cut drug prices

Why Bernie Sanders’ Ozempic crusade is misguided

Wouldn’t it be nice if we didn’t have to pay for the things we want? That’s the long and short of U.S. Sen. Bernie Sanders’ latest harebrained scheme to cut drug prices. In the Vermont independent’s capacity as chairman of the Senate Health, Education, Labor and Pensions Committee, Sanders sent ...
Commentary

Read the latest on Medicaid reform

Limit Medicaid enrollment to alleviate wait times

The Biden administration is trying to help people on Medicaid see the doctor faster. The Centers for Medicare and Medicaid Services just finalized a regulation establishing a maximum wait of 15 business days for a Medicaid beneficiary to get a primary care appointment. Decreeing that wait times must be shorter ...
Commentary

People think Medicare is going bankrupt

People are pessimistic about Medicare’s longevity. Roughly 7 in 10 adults under 65 say they’re “worried” or “extremely worried” the program won’t be around when they need it, according to a new Gallup poll. That may come as no surprise. Medicare expenditures exceeded $1 trillion in 2023. They’re on track to grow by roughly $930 billion over the next ...
biosimilars

NEW ISSUE BRIEF: Biosimilar Competition Lowers Patient Drug Costs, New Competition Will Bring Even More Savings

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute provides the latest evidence that biosimilar competition is saving patients billions – and additional competition would increase savings even more. Click to download the brief From 2019-2023, patients saved $15 billion ...
Commentary

Read about latest problems with Obamacare

Enhanced Obamacare Subsidies Irresistibly Inviting for Fraud

A new study from the Paragon Health Institute reveals that they’re also an invitation to fraud. As many as five million people receive free, taxpayer-funded marketplace coverage even though they’re not eligible for such largesse. It’s far from clear how many of these patients are deliberately misleading the government and ...
Commentary

Read about the latest push for government health care

Cross out Medicare X

Democrats argue that Medicare X “would help achieve universal health care by making coverage more affordable and accessible,” especially in rural communities. Democrats claim that they just want to offer another health insurance choice. But Medicare X would simply nudge us along toward the Democrats’ endgame: a complete government takeover ...
Commentary

Fix the 340B Program to Increase Access to Medicine

House lawmakers recently introduced legislation that would at last repair a program meant to provide low-income Americans with affordable medicine. In theory, the federal 340B Program, named after the section of the 1992 law establishing it, allows hospitals serving underprivileged groups to buy medications at steep discounts. The idea was ...
Commentary

Making Medical Debts ‘Disappear’ Misguided

The Biden administration proposed a rule this month that would remove medical debt from credit reports. It’s sure to be popular, if for no other reason than that it’s expected to boost credit scores for the more than 15 million people with such debt by an average of 20 points. ...
Commentary

Small-Molecule Price Controls Are Short-Sighted

There’s never been a better time to get lung cancer in the United States. That may sound morbid. But this deadliest of cancers appears to be losing a bit of its punch. The combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over ...
Commentary

Thanks to Biden, US Insurance Market Takes It in the Teeth

When in doubt, mandate. That has long been one of the unspoken principles guiding the left’s approach to health policy. A newly finalized rule from the Biden administration offers a fresh example of this pathology in action. Starting in 2027, the reform gives states the option of adding coverage for adult dental ...
Commentary

Learn about Sen. Sanders' latest scheme to cut drug prices

Why Bernie Sanders’ Ozempic crusade is misguided

Wouldn’t it be nice if we didn’t have to pay for the things we want? That’s the long and short of U.S. Sen. Bernie Sanders’ latest harebrained scheme to cut drug prices. In the Vermont independent’s capacity as chairman of the Senate Health, Education, Labor and Pensions Committee, Sanders sent ...
Commentary

Read the latest on Medicaid reform

Limit Medicaid enrollment to alleviate wait times

The Biden administration is trying to help people on Medicaid see the doctor faster. The Centers for Medicare and Medicaid Services just finalized a regulation establishing a maximum wait of 15 business days for a Medicaid beneficiary to get a primary care appointment. Decreeing that wait times must be shorter ...
Commentary

People think Medicare is going bankrupt

People are pessimistic about Medicare’s longevity. Roughly 7 in 10 adults under 65 say they’re “worried” or “extremely worried” the program won’t be around when they need it, according to a new Gallup poll. That may come as no surprise. Medicare expenditures exceeded $1 trillion in 2023. They’re on track to grow by roughly $930 billion over the next ...
biosimilars

NEW ISSUE BRIEF: Biosimilar Competition Lowers Patient Drug Costs, New Competition Will Bring Even More Savings

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute provides the latest evidence that biosimilar competition is saving patients billions – and additional competition would increase savings even more. Click to download the brief From 2019-2023, patients saved $15 billion ...
Scroll to Top